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A monoclonal antibody (D-5) is described which selectively precipitates nRNPs Ul and U2. The antibody 
was derived from a mouse immunized with extracts from chick embryonic nuclei. By immunoblotting on 
either total proteins from purified snRNPs Ul-U6, U2-U6 or Ul only, we could demonstrate that the 
monoclonal antibody cross-reacts with the Ul RNP specific polypeptide A and the U2 RNP specific poly- 
peptide B”, thereby establishing that the two snRNP proteins share at least one epitope. D-5 precipitates 
snRNPs Ul and U2 from a variety of species, including man, chicken, mouse, rat kangaroo and Xenopus 
laevis. It will thus be a useful tool for studying structure function relationships of the two snRNP species 
in different cell systems. 
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1. INTRODUCTION 
All eucaryotic cells contain a group of small 
nuclear RNAs, the snRNAs Ul, U2, U4, US and 
U6, which are organized in the nucleoplasm in four 
discrete RNP particles [l-4]. These are the 
snRNPs Ul, U2, U5 and U4/U6. Biochemical 
fractionation, immunoprecipitation, and protein 
blotting techniques have identified 9 polypeptides 
as components of Ul RNPs, the proteins 70 kDa, 
A, B’, B, C, D, E, F and G [5-8,121. Six of these 
(B’, B, D, E, F, G) are also found in the U2 RNP 
[5,6] as well as in the snRNPs US and U4/U6 
(Bringmann, P. and Liihrmann, R., in prepara- 
tion). The U2 RNP further possesses at least two 
unique polypeptides of M, 32000 (A’) and 28500 
(B”) [6,9,10]. Patients with connective tissue 
diseases often develop autoantibodies reacting 
with some of the snRNA associated proteins [2]. 
Anti-RNP antibodies selectively precipitate Ul 
RNPs while anti-Sm antibodies react with all 
snRNPs Ul-U6 [2]. More recently, two further 
types of autoantibodies have been detected which 
* To whom correspondence should be addressed 
are less common among patients and which react 
with U2 RNPs [9,10]. 
In the nucleus the U snRNPs are associated with 
hnRNPs [13-151, consistent with the current 
thinking that all snRNPs may contribute to pre- 
mRNA processing [ 161. So far it has been ex- 
perimentally verified that the snRNPs Ul and U2 
are implicated in pre-mRNA splicing [17-201. 
Their exact function in this process is not yet 
understood, however. A role for U4 RNA in 
3 ‘-end processing of mRNA precursors has been 
proposed [21], but experimental proof for this no- 
tion is still lacking. One approach to a better 
understanding of the functions of individual U 
snRNPs is to use snRNP class-specific antibodies 
for neutralizing the function of the snRNP species 
in question, either in vivo or in appropriate in vitro 
systems. Using anti-RNP and anti-Sm autoan- 
tibodies [17,22] as well as snRNA cap specific an- 
tibodies [18], this approach has already been suc- 
cessfully applied for demonstrating the involve- 
ment of Ul RNP in splicing reactions. The usage 
of naturally occurring snRNP-reactive autoan- 
tibodies for the unravelling of the functions of 
other snRNPs is hampered, however, for several 
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reasons. Either snRNP class-specific autoan- 
tibodies have not yet been detected (which is true 
of snRNPs US and U4/U6), or they often are con- 
taminated by other autoantibodies, a general 
drawback of using autoantisera. One approach 
which bypasses these problems is the use of 
monoclonal antibodies; these reagents may be ex- 
pected to react specifically with only one or at most 
a defined subset of the snRNPs. We here describe 
a monoclonal antibody (D-5) that reacts selectively 
with snRNPs Ul and U2 due to cross-reactivity 
with the Ul specific polypeptide A and the U2 
specific polypeptide B ,,. 
2. MATERIALS AND METHODS 
2.1. Antibodies 
The immunization of Balb/c mice with extracts 
from chick embryonic nuclei, fusion of spleen cells 
to myeloma cells, and the establishment of perma- 
nent hybridoma cell lines have been described [23]. 
Monoclonal antibody D-5 (an IgGr) was harvested 
from hybridoma supernatants, precipitated by 
45% saturated ammonium sulfate and dialysed 
against PBS, or purified by immuno-affinity 
chromatography with rabbit anti-mouse IgG 
coupled to CNBr-Sepharose. Antibodies specific 
for 2,2,7-trimethylguanosine (msG) were obtained 
as in [24] by immunizing rabbits with a conjugate 
of human serum albumin and m3G. 
2.2. Cell culture 
PtK2 rat kangaroo cells and XLKE Xenopus 
laevis cells were grown as monolayers in the 
presence of 10% fetal calf serum (Boehringer, 
Mannheim). PtK2 cells were kept in Dulbecco’s 
modified Eagle’s medium (DMEM, Flow 
Laboratories) at 37”C, while Xenopus cells were 
cultured at 25°C in DMEM diluted 6 : 7 with sterile 
water. Cells were labelled for 16 h with [32P]or- 
thophosphate (10 &i/ml) in phosphate-free 
Eagle’s minimal essential medium (MEM, Flow 
Laboratories) supplemented with non-essential 
amino acids (Flow Laboratories) and 10% dialyzed 
fetal calf serum. HeLa and Ehrlich ascites cells 
(EATC) were grown in suspension culture at 37°C 
in a medium consisting of Eagle’s MEM, 5% 
newborn calf serum (Biochrome, Berlin), 50 pg/ml 
penicillin and lOOpg/ml streptomycin. They were 
labelled with [32P]orthophosphate (10 &i/ml) in 
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phosphate-free MEM with 5% dialyzed fetal calf 
serum. D-5 hybridoma cells were grown in RPM1 
1640 (Flow Laboratories) supplemented with 10% 
fetal calf serum. 
2.3. Radioimmunoprecipitation and immuno- 
blotting 
Cellular and nuclear extracts were prepared as in 
[25]; precipitation of antigen-antibody-complexes 
by Protein A-Sepharose was carried out as de- 
scribed by Matter et al. [26]. In the case where 
monoclonal antibody D-5 was used, rabbit anti- 
mouse IgG were prebound to protein A-Sepharose 
beads. Immunoblotting was performed according 
to Towbin et al. [27], and visualization of antigenic 
proteins on nitrocellulose strips was achieved 
essentially as described by Habets et al. [28]. 
2.4. Isolation of snRNPs 
Total nucleoplasmic snRNPs Ul-U6 from 
nuclear extracts of HeLa cells were purified in a 
one-step procedure by affinity chromatography us- 
ing antibodies specific for msG as described [29]. 
Bound snRNPs were desorbed specifically from 
the column with an excess of nucleoside msG. Ul 
snRNPs were obtained from anti-m3G affinity- 
purified snRNPs Ul-U6 by chromatography on 
DEAE-Sepharose [5]. To obtain an snRNP mix- 
ture containing only snRNPs U2, U5 and U4/U6 
(U2-U6), anti-msG affinity-purified snRNPs 
U l-U6 (see above) were depleted of Ul snRNPs 
by passaging the total snRNP mixture twice over 
an anti-RNP immune affinity column according to 
Billings and Hoch [7], except that anti-(Ul)RNP 
IgG from a MCTD patient serum was used instead 
of monoclonal anti-(Ul)RNP antibody. 
3. RESULTS AND DISCUSSION 
The D-5 monoclonal antibody, identified here as 
a reagent specific for snRNPs Ul and U2, was 
originally raised against chicken nuclear antigens 
[20]; its production and a preliminary account of 
its reactivity toward chick embryo fibroblasts have 
been presented [23]. Because of a conspicuous im- 
munoblotting reactivity toward a protein doublet 
migrating in the region of snRNP core proteins, 
D-5 hybridoma supernatant was tested for anti- 
snRNP reactivity. In a sensitive ELISA assay, D-5 
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was found to react strongly with purified snRNPs 
Ul-U6 from HeLa cells (not shown). 
Reactivity of D-5 with snRNPs was further 
verified by immunoprecipitation assays using total 
nuclear extracts of “P-1abelled HeLa cells as a 
source of snRNPs. Antibody-RNP complexes were 
precipitated with Staphylococcus aweus cells and 
RNAs contained in the immune precipitates were 
identified by polyacrylamide gel electrophoresis. 
Most interestingly, D-5 selectively precipitated the 
snRNPs Ul and U2, while absolutely no reaction 
was observed with any of the other snRNPs (fig.1). 
As D-5 did not react with deproteinized snRNAs 
(not shown) these data indicated that precipitation 
of snRNPs Ul and U2 was due either to reaction 
with a yet undiscovered protein shared only by the 
two snRNP species, or to cross-reaction with dif- 
ferent but structurally related proteins residing on 
snRNPs Ul and U2. 
The second alternative turned out to be true as 
demonstrated by protein blotting. When total pro- 
tein from purified snRNPs Ul-U6 was used for 
immunoblots, monoclonal antibody D-5 reacted 
with two proteins of about 34 and 28.5 kDa 
(fig.2B), suggesting that D-5 cross-reacts with the 
Ul specific polypeptide A and the U2 specific 
polypeptide B N (for the protein composition of the 
snRNPs Ul and U2, see section 1). This supposi- 
tion could be confirmed by the following ex- 
periments. With total protein from purified Ul 
RNPs, D-5 decorated solely the 34 kDa protein on 
immunoblots (fig.2C). This clearly demonstrates 
that D-5 does not react with the proteins B and B’ 
of 28 and 29 kDa, respectively, which are present 
in all snRNP particles Ul-U6. When, on the other 
hand, proteins from purified snRNPs U2-U6, 
which completely lacked Ul RNPs, were im- 
munoblotted, D-5 recognized only the 28.5 kDa 
protein (fig.2D). We therefore conclude that 
precipitation of snRNPs Ul and U2 is due to reac- 
tion of the monoclonal antibody D-5 with the 
polypeptides A and B”, which reside on the 
snRNPs Ul and U2, respectively. 
Though the epitope recognized by D-5 is shared 
by the two snRNP proteins it does not appear to be 
distributed among other cellular proteins. If total 
protein from HeLa cell nuclei was used for im- 
munoblotting D-5 recognized only the 34 and 
28.5 kDa proteins (fig.ZA). As shown previously, 





Fig.1. Specificity of monoclonal antibody (mAb) D-5 
for snRNPs Ul and U2 as demonstrated by 
radioimmunoprecipitation. Radioimmunoprecipitation 
assays were performed as described in section 2. RNAs 
were recovered from the immunoprecipitates by phenol 
extraction, fractionated by electrophoresis in a 10% 
polyacrylamide gel containing 7 M urea, and 
autoradiographed. Lanes: 1, RNA content of the 
nuclear extract from HeLa cells; 2, RNAs immuno- 
precipitated from the extract by mAb D-5. In lanes 3 and 
4 the X-ray film has been exposed 3-times as long as in 
lanes 1 and 2. (The RNA band moving just ahead of Ul 
RNA represents a fragment of Ul RNA, the faster 
moving double band probably represents degradation 
products of U2 RNA.) 
assayed by immunoblotting on total chicken 
nuclear proteins. Moreover, as determined by in- 
direct immunofluorescence microscopy, the 
subcellular distribution of the D-5 antigens was 
confined to the extra-nucleolar regions of the 
nucleus [23]. 
The antigenic determinant shared by the pro- 
teins A and B” appears to be highly conserved in 
evolution, as monoclonal antibody D-5 reacts with 
snRNPs Ul and U2 not only from human and 
27 
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Fig.2. As revealed by immunoblotting, mAb D-S reacts with the A protein of Ul snRNP and the B” protein of U2 
snRNP. Proteins from whole nuclei of HeLa cells (A), from anti-m3G affinity purified snRNPs Ul-U6 (B), from Ul 
snRNP (C) and snRNPs U2-U6 (D) were fractionated by electrophoresis in a 15% SDS-polyacrylamide g l [32] and 
were either stained with Coomassie brilliant blue R250 (all to the left) or electroblotted to nitrocellulose sheets and 
immunostained with mAb D-5 (all to the right) as described insection 2. Arrows indicate positions of marker proteins 
of 66, 45, 31, 21.5 and 14.4 kDa (from top to bottom). 
chicken cells but also from mouse, rat kangaroo 
and amphibian cells (fig.3). This will allow the use 
of monoclonal antibody D-5 for the analysis of 
structure-function relationships of snRNPs U 1 and 
U2 in different cell systems; most importantly also 
for microinjection in X. laevis oocytes. 
The cross-reactivity of polypeptides A and B” 
with monoclonal antibody D-5 is the second in- 
cidence of a shared epitope among distinct proteins 
residing on different snRNP particles. Previously 
it had been shown that a monoclonal autoantibody 
reacted simultaneously with the polypeptides B, B’ 
and D and, to some extent, with E [12,30]. It is 
possible, therefore, that snRNA-associated 
polypeptides may comprise a-family of structurally 
28 
related proteins, as observed in the case of hnRNP 
core proteins [31]. 
The distinctive reactivity of the D-5 monoclonal 
antibody is highly reminiscent of the properties of 
a novel autoimmune serum which has recently 
been detected in rare cases of patients with connec- 
tive tissue disorders [lo]. These antisera were 
noticeable for their selective precipitation of 
snRNPs Ul .and U2. By immunoblotting tech- 
niques, and using purified antibody fractions 
eluted from individual antigen bands on 
nitrocellulose blots, it could be shown that the 
anti-(Ul ,U2) sera shared autoantibodies cross- 
reacting with the snRNP polypeptides A and B” 
[lo]; in addition, however, they contained further 
Volume 201, number 1 FEBS LETTERS May 1986 
HeLa EATC PtK, 




Fig.3. The antigenic determinant recognized by mAb 
D-5 is highly conserved during evolution. Radio- 
immunoprecipitation assays with mAb D-S using cellular 
extracts from different species as antigens were per- 
formed as described in section 2. Immuno-precipitates 
were processed as described in the legend to fig.1. The 
autoradiograph shows the RNAs in the cellular extract 
of HeLa cells (lane 2), mouse Ehrlich ascites tumor cells 
(lane 4), rat kangaroo PtKz cells (lane 6) and X. laevis 
kidney epithelial cells (lane 8). Lanes 1, 3, 5 and 7 
display RNAs present in immuno-precipitates prepared 
with mAb D-S from the corresponding cellular extracts 
(lane 3: mouse cells contain two species of Ul snRNA, 
Ulb and Ula (2); lane 5: the RNA band migrating ahead 
of U2 most probably represents a 5 ‘-terminal fragment 
of native U2 RNA, as indicated by the finding that this 
RNA also reacts with anti-m& IgG (not shown). The 
lower Ul snRNA band lacks a m3G cap and is most 
likely degraded from the native Ul snRNA. 
autoantibodies against other Ul and U2 specific 
proteins [lo]. Competitive binding studies showed 
that binding of the monoclonal antibody D-5 and 
the anti-(Ul,U2) autoantibodies to isolated 
snRNPs is mutually exclusive (unpublished), in- 
dicating that these antibodies recognize the same 
region of the snRNP polypeptides A and B”. 
Thus, the D-5 monoclonal antibody may not only 
be valuable in further elucidating the biological 
role of the snRNPs Ul and U2, but may also be 
used to measure the occurrence of anti-(Ul,U2) 
autoantibodies in sera from patients with connec- 
tive tissue disorders by a simple competition assay. 
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